Dermal matrix proteins initiate re-epithelialization but are not sufficient for coordinated epidermal outgrowth in a new fish skin culture model.
We have established a new culture system to study re-epithelialization during fish epidermal wound healing. In this culture system, fetal bovine serum (FBS) stimulates the epidermal outgrowth of multi-cellular layers from scale skin mounted on a coverslip, even when cell proliferation is blocked. The rate of outgrowth is about 0.4 mm/h, and at 3 h after incubation, the area occupied by the epidermal sheet is nine times larger than the area of the original scale skin. Cells at the bottom of the outgrowth show a migratory phenotype with lamellipodia, and "purse string"-like actin bundles have been found over the leading-edge cells with polarized lamellipodia. In the superficial cells, re-development of adherens junctions and microridges has been detected, together with the appearance and translocation of phosphorylated p38 MAPK into nuclear areas. Thus, this culture system provides an excellent model to study the mechanisms of epidermal outgrowth accompanied by migration and re-differentiation. We have also examined the role of extracellular matrix proteins in the outgrowth. Type I collagen or fibronectin stimulates moderate outgrowth in the absence of FBS, but development of microridges and the distribution of phosphorylated p38 MAPK are attenuated in the superficial cells. In addition, the leading-edge cells do not have apparent "purse string"-like actin bundles. The outgrowth stimulated by FBS is inhibited by laminin. These results suggest that dermal substrates such as type I collagen and fibronectin are able to initiate epidermal outgrowth but require other factors to enhance such outgrowth, together with coordinated alterations in cellular phenotype.
Matsumoto
Reiko
R
Department of Biomolecular Science, Faculty of Science, Toho University, Miyama 2-2-1, Funabashi, Chiba, Japan.
Sugimoto
Masazumi
M
D000199:Actins / Q000032:analysis / Q000378:metabolism; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002465:Cell Movement / Q000502:physiology; D049109:Cell Proliferation / Q000187:drug effects; D016895:Culture Media, Serum-Free / Q000494:pharmacology; D000078404:Epidermal Cells; D004817:Epidermis / Q000378:metabolism / Q000502:physiology*; D004847:Epithelial Cells / Q000737:chemistry / Q000166:cytology / Q000378:metabolism; D016326:Extracellular Matrix Proteins / Q000494:pharmacology / Q000502:physiology*; D066298:In Vitro Techniques; D015603:Keratinocytes / Q000737:chemistry / Q000166:cytology / Q000378:metabolism; D007797:Laminin / Q000494:pharmacology; D016685:Mitomycin / Q000494:pharmacology; D009990:Oryzias / Q000502:physiology*; D010766:Phosphorylation; D011554:Pseudopodia / Q000737:chemistry / Q000502:physiology; D012879:Skin Physiological Phenomena; D016596:Vinculin / Q000032:analysis / Q000378:metabolism; D014945:Wound Healing / Q000187:drug effects / Q000502:physiology*; D048051:p38 Mitogen-Activated Protein Kinases / Q000032:analysis / Q000378:metabolism
D000199:Actins; D016895:Culture Media, Serum-Free; D016326:Extracellular Matrix Proteins; D007797:Laminin; D016596:Vinculin; D016685:Mitomycin; D048051:p38 Mitogen-Activated Protein Kinases